The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience.

Pınar Gürsoy,Burcu Cakar,Elvina Almuradova,Murat Karateke,Basak Doganavsargil,Murat Sezak,Mustafa Harman,Bulent Karabulut

The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience.

2020

Pınar Gürsoy
Burcu Cakar
Elvina Almuradova
Murat Karateke
Basak Doganavsargil
Murat Sezak
Mustafa Harman
Bulent Karabulut

Panitumumab and cetuximab are monoclonal antibodies known to be effective in metastatic colorectal cancer (mCRC). Although the survival benefits when combined with chemotherapy have been determined...

Keywords:

KRAS
Internal medicine
Cetuximab
Monoclonal antibody
Panitumumab
Oncology
Wild type
Chemotherapy
Medicine
Colorectal cancer
FOLFIRI

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations